Pharmaceutical Manufacturing Handbook: Production and

792 MICROEMULSIONS AS DRUG DELIVERY SYSTEMS
113. Muller , M. , Mascher , H. , Kikuta , C. , Schafer , S. , Brunner , M. , and Dorner , G. , et al. ( 1997 ),
Diclofenac concentrations in defi ned tissue layers after topical administration , Clin.
Pharmacol. Therap. , 62 ( 3 ), 293 – 299 .
114. Park , K. - M. , and Kim , C. - K. ( 1999 ), Preparation and evaluation of fl urbiprofen - loaded
microemulsion for parenteral delivery , Int. J. Pharm. , 181 ( 2 ), 173 – 179 .
115. Moreno , M. A. , Ballesteros , M. P. , and Frutos , P. ( 2003 ), Lecithin - based oil - in - water
microemulsions for parenteral use: pseudoternary phase diagrams, characterization and
toxicity studies , J. Pharm. Sci. , 92 ( 7 ), 1428 – 1437 .
116. Hwang , S. R. , Lim , S. - J. , Park , J. - S. , and Kim , C. - K. ( 2004 ), Phospholipid - based microemulsion
formulation of all - trans - retinoic acid for parenteral administration , Int. J.
Pharm. , 276 ( 1 – 2 ), 175 – 183 .
117. Bourlais , C. L. , Acar , L. , Zia , H. , Sado , P. A. , Needham , T. , and Leverge , R. ( 1998 ), Ophthalmic
drug delivery systems — recent advances , Prog. Retinal Eye Res. , 17 ( 1 ), 33 – 58 .
118. Lang , J. C. ( 1995 ), Ocular drug delivery conventional ocular formulations , Adv. Drug
Del. Rev. Ocular Drug Del. , 16 ( 1 ), 39 – 43 .
119. Miller , S. C. , and Donovan , M. D. ( 1982 ), Effect of poloxamer 407 gel on the miotic
activity of pilocarpine nitrate in rabbits , Int. J. Pharm. , 12 ( 2 – 3 ), 147 – 152 .
120. Fitzgerald , P. , Hadgraft , J. , Kreuter , J. , and Wilson , C. G. ( 1987 ), A γ - scintigraphic evaluation
of microparticulate ophthalmic delivery systems: Liposomes and nanoparticles , Int.
J. Pharm. , 40 ( 1 – 2 ), 81 – 84 .
121. Calvo , P. , Vila - Jato , J. L. , and Alonso , M. J. ( 1997 ), Evaluation of cationic polymer - coated
nanocapsules as ocular drug carriers , Int. J. Pharm. , 153 ( 1 ), 41 – 50 .
122. Pignatello , R. , Bucolo , C. , Ferrara , P. , Maltese , A. , Puleo , A. , and Puglisi , G. ( 2002 ),
Eudragit RS100 nanosuspensions for the ophthalmic controlled delivery of ibuprofen ,
Eur. J. Pharm. Sci. , 16 ( 1 – 2 ), 53 – 61 .
123. Vyas , S. P. , Mysore , N. , Jaitely , V. , and Venkatesan , N. ( 1998 ), Discoidal niosome based
controlled ocular delivery of timolol maleate , Pharmazie , 53 ( 7 ), 466 – 469 .
124. Gasco , M. R. , Gallarate , M. , Trotta , M. , Bauchiero , L. , Gremmo , E. , and Chiappero , O.
( 1989 ), Microemulsions as topical delivery vehicles: Ocular administration of timolol ,
J. Pharm. Biomed. Anal. , 7 ( 4 ), 433 – 439 .
125. Gallarate , M. , Gasco , M. R. , Trotta , M. , Chetoni , P. , and Saettone , M. F. ( 1993 ), Preparation
and evaluation in vitro of solutions and o/w microemulsions containing levobunolol
as ion - pair , Int. J. Pharm. , 100 ( 1 – 3 ), 219 – 225 .
126. Hasse , A. , and Keipert , S. ( 1997 ), Development and characterization of microemulsions
for ocular application , Eur. J. Biopharm. , 43 , 179 – 183 .
127. Siebenbrodt , I. , and Keipert , S. ( 1993 ), Poloxamer - Systems as potential ophthalmics II.
Microemulsions , Eur. J. Biopharm. , 39 , 25 – 30 .
128. Alany , R. G. , Rades , T. , Nicoll , J. , Tucker , I. G. , and Davies , N. M. ( 2006 ), W/O microemulsions
for ocular delivery: Evaluation of ocular irritation and precorneal retention ,
J. Controlled Release , 111 ( 1 – 2 ), 145 – 152 .
129. Vandamme , T. F. ( 2002 ), Microemulsions as ocular drug delivery systems: Recent developments
and future challenges , Prog. Retinal Eye Res. , 21 ( 1 ), 15 – 34 .